Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Karathanos, A
339  Ergebnisse:
Personensuche X
?
1

Clinical efficacy and safety outcomes of bempedoic acid for..:

Lin, Y ; Parco, C ; Karathanos, A...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
2

ACTION and NCDR risk models outperform GRACE for prediction..:

Parco, C ; Kosejian, L ; Quade, J...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
3

Impact of right ventricular volume and function assessed by..:

Spieker, M ; Marpert, J ; Afzal, S...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
4

Uninterrupted direct oral anticoagulants and vitamin K anta..:

Brockmeyer, M ; Lin, Y ; Parco, C...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
5

Iron status, anemia and functional capacity in adults with ..:

Karathanos, A ; Simon, I ; Brockmeyer, M...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
6

Standardized risk management in catheterization procedures ..:

Troestler, J ; Parco, C ; Brockmeyer, M...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
7

283Endovascular thrombectomy as a means to improve survival..:

Lin, Y ; Schulze, V ; Brockmeyer, M...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
8

P6268Cardiovascular outcomes of new anti-diabetic agents - ..:

Lin, Y ; Parco, C ; Brockmeyer, M...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
9

P2792Preoperative levosimendan improves survival in patient..:

Brockmeyer, M ; Lin, Y ; Karathanos, A...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
10

P957Survival benefits of routine glycoprotein IIb/IIIa inhi..:

Karathanos, A ; Lin, Y F ; Dannenberg, L...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
11

P1853Comparative evaluation of risk model performance for p..:

Wolff, G ; Klein, K ; Parco, C...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
12

P3593Interventional patent foramen ovale closure or medical..:

Wolff, G ; Lin, Y ; Karathanos, A...
European Heart Journal.  39 (2018)  suppl_1 - p. , 2018
Link: https://doi.org/10.1093/..
 
?
13

P3624Glycoprotein IIb/IIIa inhibitor therapy in ST-segment ..:

Wolff, G ; Karathanos, A ; Dannenberg, L...
European Heart Journal.  39 (2018)  suppl_1 - p. , 2018
Link: https://doi.org/10.1093/..
 
?
14

P6355Validation of an NCDR-score-based risk model for cardi..:

Wolff, G ; Lin, Y ; Quade, J...
European Heart Journal.  39 (2018)  suppl_1 - p. , 2018
Link: https://doi.org/10.1093/..
 
?
15

2920Implantable cardioverter/defibrillators for primary pre..:

Wolff, G. ; Lin, Y. ; Karathanos, A....
European Heart Journal.  38 (2017)  suppl_1 - p. , 2017
Link: https://doi.org/10.1093/..
 
1-15